Assignee
PELOTON THERAPEUTICS INC
US·18 granted patents·8 pending applications·104 citations·filing 2014–2025
Top patents by PatentIndex Score
26 records- 0196US9796697B2Tricyclic inhibitors of HIF-2-alpha and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 24, 2017·18 cites·18 claims
- 0295US10155726B2Substituted pyridines and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Dec 18, 2018·14 cites·24 claims
- 0393USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 0493US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 0593US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 0693US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 0792US11591355B2CD73 inhibitors and uses thereofPELOTON THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·25 claims
- 0892US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 0989US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 1087US10335388B2Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·4 cites·21 claims
- 1187US10278942B2Compositions for use in treating pulmonary arterial hypertensionPELOTON THERAPEUTICS INC·Filed 2016·Granted May 7, 2019·7 cites·16 claims
- 1286US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 1381US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 1479US2025326711A1Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereofPELOTON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1575US10512626B2Compositions for use in treating glioblastomaPELOTON THERAPEUTICS INC·Filed 2016·Granted Dec 24, 2019·1 cites·17 claims
- 1672US10786480B2Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereofPELOTON THERAPEUTICS INC·Filed 2019·Granted Sep 29, 2020·1 cites·29 claims
- 1772US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1868US12358870B2Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereofPELOTON THERAPEUTICS INC·Filed 2019·Granted Jul 15, 2025·0 cites·12 claims
- 1960US2019015377A1Compositions for Use in Treating Pulmonary Arterial HypertensionPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2060US2024294548A1Tricyclic sultams and sulfamides as antitumor agentsPELOTON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2156US2020115404A1Cd73 inhibitors and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2246US2021015764A1Methods of reducing inflammation of the digestive system with inhibitors of hif-2- alphaPELOTON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2344US2022081407A1Methods of preparing substituted indanesPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2442US2018049995A1Hif-2-alpha inhibitor polymorphsPELOTON THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2540US12331068B2Compositions and methods for inhibiting CD73PELOTON THERAPEUTICS INC·Filed 2019·Granted Jun 17, 2025·0 cites·20 claims
- 2635US10040767B2Benzimidazole derivatives and uses thereofPELOTON THERAPEUTICS INC·Filed 2015·Granted Aug 7, 2018·0 cites·23 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →